Evidence map›Paper›PMID 24343605›Full record

ArticleThe Pediatric infectious disease journal2014

Preparing for the scale-up of rotavirus vaccine introduction in Africa: establishing surveillance platforms to monitor disease burden and vaccine impact.

Jason M Mwenda, Jacqueline E Tate, A Duncan Steele, Umesh D Parashar

Open access · greenAbstract read
In one paragraph

Article in The Pediatric infectious disease journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Jason M MwendaFrom the *World Health Organization, Regional Office for Africa, Brazzaville, Republic of Congo, †National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia; and ‡Bill & Melinda Gates Foundation, Seattle, Washington.
Jacqueline E Tate
A Duncan Steele
Umesh D Parashar
National Center for Immunization and Respiratory Diseases · USBill & Melinda Gates Foundation · US

Funding

Intramural CDC HHS CC999999World Health Organization 001
6 · The paper itself

Abstract

Countries in Africa have begun introducing rotavirus vaccines in their national immunization programs, and wide-scale rollout across the continent is expected during the next few years. In preparation for vaccine introduction, many countries initiated surveillance for rotavirus and other studies to document disease burden, to describe the epidemiology and to monitor circulating rotavirus strains in Africa. In addition, 2 countries sought to systematically investigate cases of intussusception, a rare adverse event that has been associated with rotavirus vaccines in some settings. The ongoing surveillance provided data that will serve as a baseline against which the impact of rotavirus vaccines in Africa can be assessed.

Indexed as

AfricaChild, PreschoolHospitalizationHumansImmunization ProgramsInfantInfant, NewbornIntussusceptionPublic Health SurveillanceRotavirus InfectionsRotavirus VaccinesRotavirus Vaccines

Identifiers

PMID24343605
PMCPMC11977321
OpenAlexW2327612430

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.